Holen Sie sich die Stockscreener-App
1.0001
2.02%
0.0198
Schlusskurs vom Vortag:
$0.9803
Offen:
$0.98
24-Stunden-Volumen:
64,227
Relative Volume:
0.76
Marktkapitalisierung:
$17.19M
Einnahmen:
$52.68M
Nettoeinkommen (Verlust:
$-4.44M
KGV:
-3.7998
EPS:
-0.2632
Netto-Cashflow:
$-2.26M
1W Leistung:
+1.02%
1M Leistung:
-19.35%
6M Leistung:
-11.50%
1J Leistung:
+16.03%
1-Tages-Spanne:
$0.98
$1.015
1-Wochen-Bereich:
$0.9496
$1.06
52-Wochen-Spanne:
$0.79
$1.6481
Iridex Corp Stock (IRIX) Company Profile
Firmenname
Iridex Corp
Sektor
Branche
Telefon
(650) 940-4700
Adresse
1212 TERRA BELLA AVE, MOUNTAIN VIEW, CA
Compare IRIX vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IRIX
Iridex Corp
|
1.0001 | 16.85M | 52.68M | -4.44M | -2.26M | -0.2632 |
ABT
Abbott Laboratories
|
102.04 | 178.75B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
331.83 | 126.97B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
86.19 | 111.22B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
62.50 | 93.36B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
81.02 | 46.73B | 6.07B | 1.06B | 1.34B | 1.8063 |
Iridex Corp Stock (IRIX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2017-11-03 | Fortgesetzt | ROTH Capital | Buy |
| 2016-12-21 | Eingeleitet | ROTH Capital | Buy |
| 2016-01-26 | Eingeleitet | Singular Research | Buy |
| 2007-01-03 | Eingeleitet | First Albany | Buy |
Iridex Corp Aktie (IRIX) Neueste Nachrichten
IRIX Should I Buy - Intellectia AI
IRIX.O PE Ratio & Valuation, Is IRIX.O Overvalued - Intellectia AI
IRIDEX Corporation: Innovative Ophthalmic Laser Solutions for Glaucoma and Retinal Diseases - Minichart
IRIDEX (NASDAQ: IRIX) 10% holder gets interest paid in stock - Stock Titan
Iridex 10-K: Revenue $52.7M, EPS $(0.26) - TradingView
IRIDEX (NASDAQ: IRIX) boosts revenue, cuts loss and issues convertible debt - Stock Titan
IRIX.O Technical Analysis & Stock Price Forecast - Intellectia AI
Iridex's Q4 Loss Narrows Year Over Year on Retina Sales Growth - ca.finance.yahoo.com
Iridex Reports Reduced Q4 Loss Compared to Last Year Due to Increased Retina Sales - Bitget
IRIDEX Corporation (NASDAQ:IRIX) Q4 2025 Earnings Call Transcript - Insider Monkey
IRIDEX Corporation Q4 2025 Earnings Call Summary - Yahoo Finance
IRIDEX Corp reports results for the quarter ended December 31Earnings Summary - TradingView
Earnings call transcript: IRIDEX Q4 2025 sees revenue growth, narrows losses - Investing.com Canada
IRIDEX earnings beat by $0.01, revenue topped estimates - Investing.com
IRIDEX Corp (NASDAQ:IRIX) Reports Mixed Q4 Results with Revenue Growth and Narrowed Loss - ChartMill
Iridex: Q4 Earnings Snapshot - barchart.com
Iridex (IRIX) swings to positive 2025 adjusted EBITDA with 8% revenue growth - Stock Titan
Iridex Reports Fourth Quarter and Full Year 2025 Financial Results - Yahoo Finance
IPO Launch: Will IRIDEX Corporation benefit from geopolitical trendsPrice Action & Reliable Breakout Forecasts - baoquankhu1.vn
Analyst Upgrade: Does IRIDEX Corporation meet Warren Buffetts criteria2026 Institutional & Free Technical Pattern Based Buy Signals - baoquankhu1.vn
IRIDEX Corp expected to post a loss of 2 cents a shareEarnings Preview - TradingView
Signal Recap: Is IRIDEX Corporation showing insider buyingEarnings Miss & Accurate Intraday Trading Signals - baoquankhu1.vn
IRIDEX (IRIX) Projected to Post Earnings on Thursday - Defense World
Iridex Corporation Signs New Office Lease at Hellyer Oaks Technology Park in San Jose - Minichart
Iridex signs lease for new San Jose headquarters with 90-month term - Investing.com
Iridex signs lease for new San Jose headquarters with 90-month term By Investing.com - Investing.com South Africa
IRIDEX (IRIX) signs long-term San Jose headquarters lease with rent escalators - Stock Titan
Iridex to Report Fourth Quarter and Full Year 2025 Financial Results on March 26, 2026 - The Manila Times
Eye laser firm Iridex schedules March 26 reveal of 2025 results - Stock Titan
Insider Buying: Romeo Dizon Acquires Additional Shares of IRIDEX Corp (IRIX) - GuruFocus
Iridex CFO Dizon buys $1398 in IRIX stock By Investing.com - za.investing.com
Iridex CFO Dizon buys $1398 in IRIX stock - Investing.com
IRIX Earnings History & Surprises | EPS & Revenue Results | IRIDEX CORP (NASDAQ:IRIX) - ChartMill
IRIX SEC FilingsIridex 10-K, 10-Q, 8-K Forms - Stock Titan
IRIDEX (IRIX): Why This Micro-Cap Laser Stock Just Spiked – And What’s Next - AD HOC NEWS
Iridex CFO Dizon buys shares worth $2.9k - Investing.com Australia
Iridex CFO Dizon buys shares worth $2.9k By Investing.com - Investing.com South Africa
MSN Money - MSN
What’s the analyst consensus on IRIDEX Corporation2025 Momentum Check & Weekly High Return Opportunities - mfd.ru
Is IRIDEX Corporation stock a safe haven assetWeekly Stock Recap & Precise Swing Trade Alerts - mfd.ru
Iridex CFO Dizon buys $1.4k in IRIX stock By Investing.com - Investing.com South Africa
Iridex CFO Dizon buys $1.4k in IRIX stock - Investing.com South Africa
Iridex to relocate headquarters from Mountain View to San Jose By Investing.com - Investing.com South Africa
Iridex (IRIX) Plans Headquarters Relocation to San Jose - GuruFocus
Iridex to relocate headquarters from Mountain View to San Jose - Investing.com
Iridex Announces Plans to Relocate Headquarters - Yahoo Finance
Iridex CFO Dizon buys $1587 in company stock - Investing.com India
Iridex CFO Dizon buys $1587 in company stock By Investing.com - Investing.com Australia
Finanzdaten der Iridex Corp-Aktie (IRIX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Iridex Corp-Aktie (IRIX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Dizon Romeo R | Chief Financial Officer |
Feb 17 '26 |
Buy |
1.34 |
2,200 |
2,942 |
119,890 |
| Dizon Romeo R | Chief Financial Officer |
Feb 12 '26 |
Buy |
1.43 |
1,500 |
2,145 |
117,690 |
| Dizon Romeo R | Chief Financial Officer |
Feb 10 '26 |
Buy |
1.46 |
1,000 |
1,460 |
116,190 |
| Dizon Romeo R | Chief Financial Officer |
Feb 03 '26 |
Buy |
1.38 |
2,500 |
3,450 |
115,190 |
| Dizon Romeo R | Chief Financial Officer |
Jan 29 '26 |
Buy |
1.44 |
1,101 |
1,588 |
112,690 |
| Dizon Romeo R | Chief Financial Officer |
Jan 28 '26 |
Buy |
1.46 |
1,300 |
1,898 |
111,589 |
| Dizon Romeo R | Chief Financial Officer |
Jan 27 '26 |
Buy |
1.48 |
3,385 |
5,009 |
110,289 |
| Dizon Romeo R | Chief Financial Officer |
Jan 26 '26 |
Buy |
1.52 |
1,243 |
1,889 |
106,904 |
| Dizon Romeo R | Chief Financial Officer |
Jan 23 '26 |
Buy |
1.48 |
5,221 |
7,716 |
105,661 |
| Dizon Romeo R | Chief Financial Officer |
Jan 21 '26 |
Buy |
1.50 |
2,159 |
3,233 |
100,440 |
0.25%
0.37%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):